AOP Products
AOP Health
Products and Therapies
This pages provides further information for professionalsDocCheck Login
It is the declared goal of AOP Health to continuously provide new therapeutic options to patients with rare diseases
Learn more about our current product portfolio in hemato-oncology and its current availability in the DACH countries
: AOP ProductsBESREMi®
is indicated as monotherapy for the treatment of adult patients with polycythemia vera without symptomatic splenomegalyLast updated: 04/2022- : AOP Products
Thromboreductin®
is applied for reduction of elevated blood platelet counts in patients with essential thrombocythemia
Last updated: 04/2022 - : AOP Products
Anagrelide AOP
licensed generic of Thromboreductin®: same medical-scientific background and same data
Last updated: 04/2022